Virtual care tech firm Biofourmis lands $300m vote of confidence
The digital medicine solutions developer has received $300m in a Series D investment round, which will be used to help scale up its virtual care offerings.
The digital medicine solutions developer has received $300m in a Series D investment round, which will be used to help scale up its virtual care offerings.
The drug company, which uses artificial intelligence to discover and advance repurposed drugs, is harnessing the technology to find a treatment for Crohn’s.
The virtual research organization has developed digital instruments designed for assessing stools and recording crying episodes in pediatric clinical studies.